Filing Details

Accession Number:
0001315406-20-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-21 14:01:04
Reporting Period:
2020-08-19
Accepted Time:
2020-08-21 14:01:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
12208 Bio-Rad Laboratories Inc. BIO, BIOB Laboratory Analytical Instruments (3826) 941381833
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1292816 Giovanni Magni C/o Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules CA 94547
Evp, Chief Strategy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Bio-Rad A Common Stock Acquisiton 2020-08-19 3,500 $84.57 15,935 No 4 M Direct
Bio-Rad A Common Stock Acquisiton 2020-08-19 3,500 $98.04 19,435 No 4 M Direct
Bio-Rad A Common Stock Acquisiton 2020-08-19 3,250 $107.32 22,685 No 4 M Direct
Bio-Rad A Common Stock Acquisiton 2020-08-19 3,200 $117.00 25,885 No 4 M Direct
Bio-Rad A Common Stock Acquisiton 2020-08-19 3,000 $119.54 28,885 No 4 M Direct
Bio-Rad A Common Stock Acquisiton 2020-08-19 2,000 $139.56 30,885 No 4 M Direct
Bio-Rad A Common Stock Acquisiton 2020-08-19 1,200 $160.37 32,085 No 4 M Direct
Bio-Rad A Common Stock Acquisiton 2020-08-19 1,000 $215.98 33,085 No 4 M Direct
Bio-Rad A Common Stock Acquisiton 2020-08-19 500 $326.15 33,585 No 4 M Direct
Bio-Rad A Common Stock Disposition 2020-08-19 315 $517.64 33,270 No 4 S Direct
Bio-Rad A Common Stock Disposition 2020-08-19 5,392 $518.76 27,878 No 4 S Direct
Bio-Rad A Common Stock Disposition 2020-08-19 1,133 $519.89 26,745 No 4 S Direct
Bio-Rad A Common Stock Disposition 2020-08-19 5,668 $520.94 21,077 No 4 S Direct
Bio-Rad A Common Stock Disposition 2020-08-19 339 $521.86 20,738 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-08-19 3,500 $0.00 3,500 $84.57
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-08-19 3,500 $0.00 3,500 $98.04
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-08-19 3,250 $0.00 3,250 $107.32
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-08-19 3,200 $0.00 3,200 $117.00
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-08-19 3,000 $0.00 3,000 $119.54
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-08-19 2,000 $0.00 2,000 $139.56
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-08-19 1,200 $0.00 1,200 $160.37
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-08-19 1,000 $0.00 1,000 $215.98
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-08-19 500 $0.00 500 $326.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-09-08 No 4 M Direct
0 2021-11-04 No 4 M Direct
0 2022-09-12 No 4 M Direct
0 2023-09-11 No 4 M Direct
0 2024-09-10 No 4 M Direct
500 2025-09-11 No 4 M Direct
800 2026-09-08 No 4 M Direct
1,500 2027-09-05 No 4 M Direct
2,000 2028-09-04 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.34 to $518.33, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.38 to $519.25, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.39 to $520.37, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $520.51 to $521.51, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $521.73 to $522.05, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The option vests in five equal annual installments beginning on September 8, 2011.
  7. The option vests in five equal annual installments beginning on November 4, 2012.
  8. The option vests in five equal annual installments beginning on September 12, 2013.
  9. The option vests in five equal annual installments beginning on September 11, 2014.
  10. The option vests in five equal annual installments beginning on September 10, 2015.
  11. The option vests in five equal annual installments beginning on September 11, 2016.
  12. The option vests in five equal annual installments beginning on September 8, 2017.
  13. The option vests in five equal annual installments beginning on September 5, 2018.
  14. The option vests in five equal annual installments beginning on September 4, 2019.